Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ocular extractives eye drops
- Development stage
- Unknown
- Lead developer
- Guoguang Pharmaceutical
- Modality
- Peptides
- Administration
- Ophthalmic
01
Overview
Ocular Extractives Eye Drops, marketed under the brand name Shi Bo Shi by Hangzhou Guoguang Pharmaceutical, is a biological ophthalmic preparation used to facilitate corneal repair and wound healing. The drug is composed of ocular extractives, which are derived from the eyes of healthy cattle or pigs and contain a variety of amino acids and peptides. These components provide essential nutritional support to ocular tissues, enhance local metabolic processes, and promote the regeneration of corneal epithelial cells. It is clinically indicated for the treatment of keratitis, corneal ulcers, and ocular injuries, and is also utilized to accelerate recovery following ophthalmic surgical procedures.
- Brand names
- Shi Bo Shi视博士
- Other names
- 眼氨肽滴眼液Ocular Extractives Eye Drops
Beyond the preview
Go deeper on ocular extractives eye drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ocular extractives eye drops.